Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 48 out of 100. Risk factors

Topic: Risk, prevention and care in population studies

Alzheimer's disease and related dementia (ADRD) are becoming increasingly prevalent and are predicted to affect up to 153 million globally by 2050. Outside of biomarkers that measure pathology, there is a lack of methods to quantify and study complex behaviors such as driving and managing finances that precede cognitive decline among older adults. The DRIVES Project at Washington University School of Medicine has developed a pipeline to measure naturalistic driving behavior of older adult drivers enrolled in longitudinal studies of aging and ADRD. This driving behavior is captured in the form of tabular data for each trip a participant takes and is processed in two formats: low-frequency driving data, comprising approximately 2.8 million trips (37 GB), and high-frequency driving data, with approximately 1.4 million trips (2.6 TB). This pipeline also captures common participant sociodemographic characteristics, clinical features, and environmental context across various weather conditions, as well as the Area Deprivation Index and the Social Vulnerability Index, to comprehensively characterize the multidimensional nature of neurodegenerative processes among older adults.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Matthew, B., Brown David, C., Chen, C., Noor, A.-H., Ramon, C., Yiqi, Z., et al. (2025). A combined naturalistic driving, clinical, and neurobehavioral data set for investigating aging and dementia. Scientific data. https://doi.org/10.1038/s41597-025-05554-z

Vancouver

Matthew B, Brown David C, Chen C, Noor A.-H, Ramon C, Yiqi Z, et al. A combined naturalistic driving, clinical, and neurobehavioral data set for investigating aging and dementia. Scientific data. 2025. doi:10.1038/s41597-025-05554-z. PMID: 40651997.

BibTeX

@article{matthew2025-40651997,
  author  = {Matthew, Blake and Brown David, C. and Chen, Chen and Noor, Al-Hammadi and Ramon, Casanova and Yiqi, Zhu and Babulal Ganesh, M.},
  title   = {{A combined naturalistic driving, clinical, and neurobehavioral data set for investigating aging and dementia}},
  journal = {Scientific data},
  year    = {2025},
  doi     = {10.1038/s41597-025-05554-z},
  pmid    = {40651997},
  url     = {https://doi.org/10.1038/s41597-025-05554-z}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 7 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.

Key findings

Why it matters

This project provides a large set of driving data from older adults along with clinical and social information, which could help researchers study behaviors that change before cognitive decline is detected. It does not test any treatment, prevention, or cure, and is a data resource rather than a study of outcomes.

Study details

How this study scored 48/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 2 of 4; Study design 7 of 12; Strength of evidence 3 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomised / blinded 0 of 2; Times cited 2 of 7; Citations per year 2 of 5; Impact for its field and year left out, no data; Cited by studies here 0 of 6; Still being cited 1 of 4; Senior author's track record 2 of 4; Institution's track record 2 of 3; Multi-centre collaboration 1 of 3; Indexed in PubMed 2 of 2; Free to read 0 of 2. 45 of the 94 points it could be judged on, which is 48 of 100. Total 48 of 100.45 of the 94 points we could judge = 48 of 100

Published in a peer-reviewed journal, and it is a longitudinal study following the same people over time. Scored zero for sample size, effect reported, studied in people and randomised / blinded because the record does not state it. We have no data on impact for its field and year, so that was left out: it earned 45 of the 94 points we could judge it on, which is 48 out of 100.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Scientific data)
Journal's citation record 2 / 4 Scientific Data: journal h-index 215 (OpenAlex, 2026-10-29)
Study design 7 / 12 A longitudinal study following the same people over time
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 2 / 7 Cited 9 times (OpenAlex, 2026-10-17)
Citations per year 2 / 5 3.0 citations a year over 3 year(s) since 2025
Impact for its field and year — / 6 No field-weighted citation impact (OpenAlex has none yet) — left out of this score
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 1 / 4 Cited 9 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author Ganesh Muneshwar Babulal: h-index 31 (OpenAlex, whole career)
Institution's track record 2 / 3 Washington University in St. Louis: institution h-index 1,947 (OpenAlex)
Multi-centre collaboration 1 / 3 OpenAlex lists 3 institution(s) in 2 countries
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 40651997)
Free to read 0 / 2 Behind a paywall — scores zero
Points 45 / 94 Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 45 of the 94 points we could judge it on is 48 out of 100.
Total 48 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.

Related studies in Risk factors

Also tagged “prevalence”

1,224 studies in the library carry the topic tag “prevalence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,224 tagged studies.

Similar studies

More on Risk factors

See all studies in Risk factors →